Last reviewed · How we verify
NCT03097445
Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up
NA trial testing Nicotine patch in Smoking Cessation in 1,000 participants. Completed in 22 August 2019.
22 August 2019
Quick facts
| Lead sponsor | Centre for Addiction and Mental Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 1,000 |
| Start date | 4 June 2017 |
| Primary completion | 22 August 2019 |
| Estimated completion | 22 August 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Nicotine patch (nicotine-patch) — full drug profile →
Conditions studied
- Smoking Cessation — all drugs for Smoking Cessation →
Sponsor
Centre for Addiction and Mental Health — full company profile →
Who can join
18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will perform a 5-year follow-up survey of participants in a randomized controlled trial that evaluated the effectiveness of providing 5 weeks of free NRT (in the form of the nicotine patch) by expedited postal mail without behavioural assistance to regular adult smokers recruited across Canada interested in receiving it (clinicaltrials.gov Identifier: NCT01429129).
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Long-term effectiveness of mailed nicotine replacement therapy: study protocol of a randomized controlled trial 5-year follow-up.
Kushnir V, Selby P, Zawertailo L, Tyndale RF, et al · · 2017 · cited 6× · PMID 28720080 · DOI 10.1186/s12889-017-4586-z -
Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation.
Cunningham JA, Kushnir V, Selby P, Zawertailo L, et al · · 2020 · cited 2× · PMID 32150239 · DOI 10.1001/jamainternmed.2020.0001 -
To send or not to send: weighing the costs and benefits of mailing an advance letter to participants before a telephone survey.
Schell C, Godinho A, Kushnir V, Cunningham JA. · · 2018 · cited 1× · PMID 30442187 · DOI 10.1186/s13104-018-3920-6
Verify or expand the search:
- PubMed search for NCT03097445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nicotine patch
Trials testing the same drug.
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT06053567 — Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity. · Phase 3 · recruiting
- NCT05413122 — Evaluating Smoking Cessation Interventions for PWH in South Africa · Phase 2, PHASE3 · recruiting
- NCT05487807 — Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia · Phase 1 · recruiting
- NCT05351606 — Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya · Phase 4 · completed
Other recruiting trials for Smoking Cessation
Currently open trials in the same condition.
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
- NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
- NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
Other Centre for Addiction and Mental Health trials
Trials by the same sponsor.
- NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
- NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
- NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
- NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
- NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03097445 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
- Last refreshed: 23 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03097445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing